On-Demand Upstream Manufacturing Webinars

1. Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes 4/20/2026

   See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.

2. Industrializing Cell Therapy With Perfusion 4/14/2026

   Explore how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.

3. Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter 4/9/2026

   Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.

4. From Fermentation To Vaccination 4/8/2026

   Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.

5. A Highly Productive, Chemically Defined Exosome Media System 3/24/2026

   Explore how chemically defined media and optimized bioreactor protocols increase exosome yields 40-fold while reducing commercial manufacturing costs from $10,000 to under $1,000 per dose.

6. Flexible Therapeutic Development: Balancing Speed, Cost, and Process 3/24/2026

   Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.

7. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

   Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

8. Flexibility Or Scale? Navigating The Single Use Vs. Stainless Steel Debate 2/12/2026

   Explore how to choose between single‑use and stainless‑steel bioreactors, outlining key advantages, limitations, and long‑term considerations essential for successful biologics scale‑up.

9. Simplified Harvest And Media Exchange In Cell Therapy 1/28/2026

   Scale-up often introduces shear stress and process variability. Learn how low-shear, single-use technology stabilizes media exchange and harvest, ensuring consistent cell quality and predictable performance.

10. Next-Level Cell Lines: An Integrated Approach To Biologic Innovation 1/22/2026

    See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.